Cancer Science Institute of Singapore, National University of, Singapore, 117599, Singapore.
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Leukemia. 2024 Sep;38(9):1906-1917. doi: 10.1038/s41375-024-02331-6. Epub 2024 Jul 5.
T-cell acute lymphoblastic leukemia (T-ALL) is a hematological malignancy arising from immature thymocytes. Unlike well-known oncogenic transcription factors, such as NOTCH1 and MYC, the involvement of chromatin remodeling factors in T-ALL pathogenesis is poorly understood. Here, we provide compelling evidence on how SWI/SNF chromatin remodeling complex contributes to human T-ALL pathogenesis. Integrative analysis of transcriptomic and ATAC-Seq datasets revealed high expression of SMARCA4, one of the subunits of the SWI/SNF complex, in T-ALL patient samples and cell lines compared to normal T cells. Loss of SMARCA protein function resulted in apoptosis induction and growth inhibition in multiple T-ALL cell lines. ATAC-Seq analysis revealed a massive reduction in chromatin accessibility across the genome after the loss of SMARCA protein function. RUNX1 interacts with SMARCA4 protein and co-occupies the same genomic regions. Importantly, the NOTCH1-MYC pathway was primarily affected when SMARCA protein function was impaired, implicating SWI/SNF as a novel therapeutic target.
T 细胞急性淋巴细胞白血病(T-ALL)是一种起源于未成熟胸腺细胞的血液系统恶性肿瘤。与众所周知的致癌转录因子,如 NOTCH1 和 MYC 不同,染色质重塑因子在 T-ALL 发病机制中的作用还知之甚少。在这里,我们提供了令人信服的证据,证明 SWI/SNF 染色质重塑复合物如何促进人类 T-ALL 的发病机制。对转录组和 ATAC-Seq 数据集的综合分析表明,与正常 T 细胞相比,T-ALL 患者样本和细胞系中 SWI/SNF 复合物的一个亚基 SMARCA4 的表达水平较高。SMARCA 蛋白功能丧失会导致多种 T-ALL 细胞系凋亡诱导和生长抑制。ATAC-Seq 分析显示,SMARCA 蛋白功能丧失后,整个基因组的染色质可及性大幅降低。RUNX1 与 SMARCA4 蛋白相互作用,并共同占据相同的基因组区域。重要的是,当 SMARCA 蛋白功能受损时,NOTCH1-MYC 途径主要受到影响,这表明 SWI/SNF 是一个新的治疗靶点。